Akorn (AKRX) Q2 2019 Earnings Call Transcript
AKRX earnings call for the period ending June 30, 2019.
Akorn
AKRX
AKRX
$4.61
-$0.09
-1.9%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive AKRX Charts
The Company manufactures and markets diagnostic and therapeutic pharmaceuticals in specialty areas such as ophthalmology, rheumatology, anesthesia and antidotes, among others.
News & Analysis: Akorn
The Fool has written over 100 articles on Akorn.
Akorn (AKRX) Q1 2019 Earnings Call Transcript
AKRX earnings call for the period ending March 31, 2019.
Here's Why Akorn Stock Rose as Much as 14.4% Today
The embattled generic-pharmaceutical manufacturer earned two new product approvals.
Akorn (AKRX) Q4 2018 Earnings Conference Call Transcript
AKRX earnings call for the period ending December 31, 2018.
Here's Why Akorn Pharmaceuticals Is Sinking Today
It looks as if the company's former suitor will get a chance to run from the altar.
Here's Why Akorn, Inc. Fell 48.6% in October
A judge gave Fresenius the green light to walk away from the now-infamous merger.
Why Infinera, Akorn, and Cal-Maine Foods Slumped Today
Learn why these stocks missed the rally.
Here's Why Akorn Inc. Collapsed Today
It's official: A judge ruled that Fresenius can abandon the previously announced acquisition of Akorn.
Here's Why Akorn, Inc. Fell as Much as 24.1% Today
The rift with Fresenius continues to make headlines.
Here's Why Akorn Inc. Fell as Much as 16.4% Today
Investors received new details explaining why Fresenius dropped its acquisition. They aren't good.
